Vaccinex Shares Are Trading Lower. The Company Provided an Update on New Clinical Findings From Its SIGNAL-AD Phase 1b/2 Trial of Pepinemab Antibody in Alzheimer's Disease.
Vaccinex Shares Are Trading Lower. The Company Provided an Update on New Clinical Findings From Its SIGNAL-AD Phase 1b/2 Trial of Pepinemab Antibody in Alzheimer's Disease.
Vaccinex股價下跌。該公司就Pepinemab抗體在阿爾茨海默病SIGNAL-AD 1b/2期試驗中的新臨床發現進行了更新。
Vaccinex Shares Are Trading Lower. The Company Provided an Update on New Clinical Findings From Its SIGNAL-AD Phase 1b/2 Trial of Pepinemab Antibody in Alzheimer's Disease.
Vaccinex股價下跌。該公司就Pepinemab抗體在阿爾茨海默病SIGNAL-AD 1b/2期試驗中的新臨床發現進行了更新。